We are regularly checking in with Pitt spinout companies to get an update on their progress in developing their products, acquiring customers and adding employees. Today we catch up with John Cordier (pictured on right) co-founder of Epistemix Inc., whose technology could not be more relevant to the current global public health challenge.
Small businesses in Western Pennsylvania are dealing with the massive economic upheaval caused by the closings and social distancing measures put in place to limit the spread of the COVID-19 virus. And with events unfolding rapidly regarding the government’s proposed relief packages, they are struggling to make decisions on whether or not to furlough employees and to determine what access to emergency financing may be available.
On Tuesday, May 14, the Innovation Institute will host a panel on Human Performance Innovation as part of Pittsburgh Life Sciences Week.
The Pitt McGowan Institute for Regenerative Medicine has racked up some impressive numbers in its 25-year existence. Researchers affiliated with McGowan have had 140 patents issued, filed more than 900 invention disclosures; had their technology licensed more than 170 times and have spun out nearly 30 companies from the University. We sat down with McGowan's director since 2011, William Wagner, to discuss the reasons behind its success and what exciting things are happening in its labs that are changing the way patients are treated for a wide range of diseases and injuries.
Pitt smashed its record for startups in Fiscal 2018, which concludes today. (Final numbers for the year will be reported next month.) One of the driving factors for the increase in startup activity is an evolution in policy at the university making it possible for faculty to take positions within a startup. Today we catch up with Globin Solutions, a recent startup formed from research from the lab of Dr. Mark Gladwin, led by Jason Rose, an assistant professor, who is the new company's CEO.